On November 23rd 2011, the Aspirin Foundation held a meeting at the Royal Society of Medicine in London to review current thinking on the potential role of aspirin in preventing cardiovascular disease and reducing the risk of cancer in older people. The meeting was supported by Bayer Pharma AG and Novacyl.

Original publication

DOI

10.3332/ecancer.2012.245

Type

Journal article

Journal

Ecancermedicalscience

Publication Date

2012

Volume

6